Key facts
- HealthEdge’s last known valuation is $2.6B (Jun 2025).
- It has raised $927.9M; the latest was Buyout/LBO ($2.6B) in Jun 2025.
- Notable investors include Bain Capital, Monroe Capital, Oaktree Capital Management, Recognize Partners, Ardan Equity — 7 tracked in total.
- HealthEdge has filed 1 Form D with the SEC, most recently Jul 2009 ($3.5M sold to 4 investors).
- Status: Privately Held (backing).
Leadership
- Raj SundarChief Strategy Officer
- Alexander SaltzmanExecutive & Senior Vice President
- Robert DuffyChief Technology Officer
- Casey LeonettiChief Operating Officer
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for HealthEdge
- ·The full record, as it builds
Funding rounds
No funding rounds for HealthEdge are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HealthEdge
Developer of an integrated financial, administrative, and clinical software designed to connect health plans, providers, and patients with end-to-end digital technology. The company's platform offers claims and benefits administration, care management, business intelligence, and portal remedies, enabling its clients to leverage new business models, improve outcomes, and reduce administrative costs in the healthcare delivery cycle effectively.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2005
- Employees
- 1,963
- Website
- healthedge.com/
- Ownership
- Privately Held (backing)
HealthEdge doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HealthEdge shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HealthEdge in its N-PORT filings yet. We sweep new filings monthly.